Bay Colony Advisory Group, Inc D Gilead Sciences, Inc. Transaction History

Bay Colony Advisory Group, Inc D

$634 Million
Q3 2024

A detailed history of Bay Colony Advisory Group, Inc D transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Bay Colony Advisory Group, Inc D holds 3,842 shares of GILD stock, worth $350,966. This represents 0.05% of its overall portfolio holdings.

Number of Shares

3,842

Previous 3,832 0.26%

Holding current value

$350,966

Previous $262,000 22.9%

% of portfolio

0.05%

Previous 0.05%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	BUY	$66.59 - $83.99 $665 - $839	10 Added 0.26%	3,842 $322,000
Q2 2024 Jul 24, 2024	BUY	$63.15 - $72.88 $757 - $874	12 Added 0.31%	3,832 $262,000
Q1 2024 Apr 30, 2024	SELL	$71.58 - $87.29 $94,342 - $115,048	-1,318 Reduced 25.65%	3,820 $279,000
Q4 2023 Jan 29, 2024	BUY	$73.27 - $83.09 $80,523 - $91,315	1,099 Added 27.21%	5,138 $416,000
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $207,179 - $226,037	-2,802 Reduced 40.96%	4,039 $302,000
Q2 2023 Aug 11, 2023	BUY	$76.01 - $86.7 $85,283 - $97,277	1,122 Added 19.62%	6,841 $527,000
Q1 2023 Apr 27, 2023	BUY	$77.31 - $88.08 $42,211 - $48,091	546 Added 10.55%	5,719 $474,000
Q4 2022 Feb 01, 2023	BUY	$62.32 - $89.47 $79,333 - $113,895	1,273 Added 32.64%	5,173 $444,000
Q3 2022 Oct 27, 2022	BUY	$59.54 - $68.01 $2,917 - $3,332	49 Added 1.27%	3,900 $241,000
Q2 2022 Aug 08, 2022	BUY	$57.72 - $65.01 $26,089 - $29,384	452 Added 13.3%	3,851 $230,000
Q1 2022 Apr 28, 2022	SELL	$57.92 - $72.58 $100,143 - $125,490	-1,729 Reduced 33.72%	3,399 $202,000
Q4 2021 Jan 28, 2022	BUY	$64.88 - $73.64 $11,873 - $13,476	183 Added 3.7%	5,128 $372,000
Q3 2021 Nov 02, 2021	SELL	$67.69 - $73.03 $292,556 - $315,635	-4,322 Reduced 46.64%	4,945 $345,000
Q2 2021 Jul 22, 2021	SELL	$63.47 - $69.35 $174,986 - $191,197	-2,757 Reduced 22.93%	9,267 $638,000
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $135,600 - $154,719	-2,260 Reduced 15.82%	12,024 $777,000
Q4 2020 Feb 02, 2021	SELL	$56.65 - $64.55 $50,531 - $57,578	-892 Reduced 5.88%	14,284 $832,000
Q3 2020 Nov 25, 2020	SELL	$62.1 - $78.08 $70,607 - $88,776	-1,137 Reduced 6.97%	15,176 $959,000
Q2 2020 Jul 23, 2020	BUY	$72.34 - $84.0 $327,700 - $380,520	4,530 Added 38.45%	16,313 $1.26 Million
Q1 2020 Apr 17, 2020	BUY	$62.63 - $80.22 $294,173 - $376,793	4,697 Added 66.29%	11,783 $881,000
Q4 2019 Jan 28, 2020	BUY	$61.62 - $67.78 $436,639 - $480,289	7,086 New	7,086 $449,000
Q4 2019 Jan 28, 2020	SELL	$61.62 - $67.78 $310,133 - $341,136	-5,033 Closed	0 $0
Q3 2019 Oct 25, 2019	BUY	$62.51 - $69.0 $314,612 - $347,277	5,033 New	5,033 $319,000
Q3 2018 Nov 05, 2018	SELL	$71.28 - $78.92 $132,509 - $146,712	-1,859 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$64.88 - $75.68 $120,611 - $140,689	1,859 New	1,859 $132,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bay Colony Advisory Group, Inc D, based on Form 13F filings with the SEC.

News

Stay updated on Bay Colony Advisory Group, Inc D with notifications on news.

Account

Bay Colony Advisory Group, Inc D Gilead Sciences, Inc. Transaction History